1. Home
  2. BBSI vs TBPH Comparison

BBSI vs TBPH Comparison

Compare BBSI & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barrett Business Services Inc.

BBSI

Barrett Business Services Inc.

HOLD

Current Price

$29.16

Market Cap

711.6M

ML Signal

HOLD

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$16.91

Market Cap

824.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBSI
TBPH
Founded
1965
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
711.6M
824.9M
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
BBSI
TBPH
Price
$29.16
$16.91
Analyst Decision
Strong Buy
Buy
Analyst Count
3
6
Target Price
$42.67
$18.40
AVG Volume (30 Days)
233.8K
478.4K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
1.10%
N/A
EPS Growth
5.05
279.13
EPS
2.08
2.06
Revenue
$920,432,000.00
$15,386,000.00
Revenue This Year
$6.59
$1.04
Revenue Next Year
$6.05
N/A
P/E Ratio
$13.99
$8.00
Revenue Growth
9.50
N/A
52 Week Low
$25.33
$8.33
52 Week High
$49.65
$21.03

Technical Indicators

Market Signals
Indicator
BBSI
TBPH
Relative Strength Index (RSI) 48.38 62.14
Support Level $28.11 $13.41
Resistance Level $29.49 $19.04
Average True Range (ATR) 1.05 0.52
MACD 0.13 0.27
Stochastic Oscillator 60.37 98.23

Price Performance

Historical Comparison
BBSI
TBPH

About BBSI Barrett Business Services Inc.

Barrett Business Services Inc is a provider of payroll administrative services and staffing services. The company categories of services include professional employer services and staffing. Professional employer services offer payroll management, payroll tax services, and workers' compensation coverage solutions, as well as workforce management services, including hiring and termination of employees. Staffing offers temporary staffing services, as well as contract staffing, long-term or indefinite on-site management, and direct placement services. The company operates in the United States of America. It generates maximum revenue from the Professional employer service fees.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.

Share on Social Networks: